Target intelligence / Profile preview

40S ribosomal protein S17 (RPS17)

Target
RPS17
Molecular classification
Other (ribosomal protein; structural constituent of ribosome)
01

Overview

40S ribosomal protein S17 (RPS17) is a highly conserved structural protein that is an essential component of the small 40S subunit of the eukaryotic ribosome, which catalyzes protein synthesis in all cells. The RPS17 protein is involved in the assembly and stability of the ribosome as well as in the ribosome's primary function: translating messenger RNA into protein. RPS17 is cytoplasmic, contains nuclear and nucleolar localization signals, and concentrates in the nucleolus during ribosome assembly. Mutations or deletions in RPS17 cause Diamond-Blackfan anemia, a rare congenital disorder characterized by erythroid failure and various congenital anomalies, highlighting the protein’s critical role in hematopoiesis[1][2][3][4][5]. RPS17 is not a typical drug target (such as a receptor, enzyme, or transporter), and no approved drugs are known to specifically interact with or modulate this protein.

Other names
Small ribosomal subunit protein eS17RPS17LRPS17L1RPS17L2MGC72007S17eS17DBA4
02

Biological functions

Protein synthesis (translation)Ribosome assemblyRNA bindingRegulation of cell divisionApoptosisPossible roles in chemical signaling pathways
03

Disease associations

Diamond-Blackfan anemiaOther (disorders of ribosome biogenesis; defects in erythropoiesis)
04

Safety considerations

Ribosomal proteins are essential for cell viability; loss-of-function or mutations may result in severe hematological disorders and developmental anomalies, but direct therapeutic targeting poses significant toxicity risk
05

Biomarkers

RPS17 mutations are markers for diagnosis of Diamond-Blackfan anemia but are not used as general treatment biomarkers

Beyond the preview

Go deeper on 40S ribosomal protein S17 (RPS17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 40S ribosomal protein S17 (RPS17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call